Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Clinical trial NCT05085496 · RECRUITING

Trial details

NCT number: NCT05085496
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Skin Squamous Cell Carcinoma Resectable Skin Squamous Cell Carcinoma Unresectable Skin Squamous Cell Carcinoma

Start date: 2022-04-19
Primary completion: 2027-09-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.